IPC Signs MoUs with the Pharmaceuticals & Medical Devices Bureau of India and National Institute of Pharmaceuticals Education & Research, Hajipur, to Promote Drug Quality, Research, and Patient Safety

• Indian Pharmacopoeia Commission (IPC) signed two MoUs — with Pharmaceuticals & Medical Devices Bureau of India (PMBI) and with NIPER, Hajipur (Bihar) — to advance drug quality, pharmacovigilance, pharmacopoeial research, and patient safety.
• Relevant for UPSC under GS-II (Health, Government Policies) and GS-III (S&T, Pharma sector); tests aspirants on the institutional ecosystem of drug regulation in India.